These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 14709946)

  • 1. Predictors of response in generalized social phobia: effect of age of onset.
    Van Ameringen M; Oakman J; Mancini C; Pipe B; Chung H
    J Clin Psychopharmacol; 2004 Feb; 24(1):42-8. PubMed ID: 14709946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nefazodone for social phobia: a clinical case series.
    Worthington JJ; Zucker BG; Fones CS; Otto MW; Pollack MH
    Depress Anxiety; 1998; 8(3):131-3. PubMed ID: 9836065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M; Russell J; Erickson J; Detke MJ; Ball S; Dinkel J; Rickels K; Raskin J
    Depress Anxiety; 2008; 25(3):182-9. PubMed ID: 17311303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder.
    Steiner M; Allgulander C; Ravindran A; Kosar H; Burt T; Austin C
    Hum Psychopharmacol; 2005 Jan; 20(1):3-13. PubMed ID: 15551351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion-SR in treatment of social phobia.
    Emmanuel NP; Brawman-Mintzer O; Morton WA; Book SW; Johnson MR; Lorberbaum JP; Ballenger JC; Lydiard RB
    Depress Anxiety; 2000; 12(2):111-3. PubMed ID: 11091936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam in social phobia: a placebo controlled pilot study.
    Zhang W; Connor KM; Davidson JR
    J Psychopharmacol; 2005 Sep; 19(5):551-3. PubMed ID: 16166192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of depression on treatment effectiveness and gains maintenance in social phobia: a naturalistic study of cognitive behavior group therapy.
    Marom S; Gilboa-Schechtman E; Aderka IM; Weizman A; Hermesh H
    Depress Anxiety; 2009; 26(3):289-300. PubMed ID: 19170088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
    Allen RP; Ritchie SY
    Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between generalized social phobia and avoidant personality disorder in a national mental health survey.
    Cox BJ; Pagura J; Stein MB; Sareen J
    Depress Anxiety; 2009; 26(4):354-62. PubMed ID: 19031488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder.
    McRae AL; Brady KT; Mellman TA; Sonne SC; Killeen TK; Timmerman MA; Bayles-Dazet W
    Depress Anxiety; 2004; 19(3):190-6. PubMed ID: 15129422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.
    Walker JR; Van Ameringen MA; Swinson R; Bowen RC; Chokka PR; Goldner E; Johnston DC; Lavallie YJ; Nandy S; Pecknold JC; Hadrava V; Lane RM
    J Clin Psychopharmacol; 2000 Dec; 20(6):636-44. PubMed ID: 11106135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
    Van Ameringen MA; Lane RM; Walker JR; Bowen RC; Chokka PR; Goldner EM; Johnston DG; Lavallee YJ; Nandy S; Pecknold JC; Hadrava V; Swinson RP
    Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study.
    Vaishnavi S; Alamy S; Zhang W; Connor KM; Davidson JR
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1464-9. PubMed ID: 17698275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
    Allgulander C; Hartford J; Russell J; Ball S; Erickson J; Raskin J; Rynn M
    Curr Med Res Opin; 2007 Jun; 23(6):1245-52. PubMed ID: 17559726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial aggregation of anxiety-related quantitative traits in generalized social phobia: clues to understanding "disorder" heritability?
    Stein MB; Chartier MJ; Lizak MV; Jang KL
    Am J Med Genet; 2001 Jan; 105(1):79-83. PubMed ID: 11425006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
    Pollack MH; Endicott J; Liebowitz M; Russell J; Detke M; Spann M; Ball S; Swindle R
    J Psychiatr Res; 2008 Oct; 42(12):1042-9. PubMed ID: 18221755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH; Tiller J; Xie F; Trivedi MH
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.